EUR 2.86
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 7.49 Million EUR | -0.92% |
2022 | 7.56 Million EUR | 190.46% |
2021 | 2.6 Million EUR | -42.86% |
2020 | 4.56 Million EUR | 396.75% |
2019 | 918.06 Thousand EUR | 20.9% |
2018 | 759.36 Thousand EUR | -58.54% |
2017 | 1.83 Million EUR | -72.2% |
2016 | 6.58 Million EUR | 203.24% |
2015 | 2.17 Million EUR | -16.17% |
2014 | 2.59 Million EUR | 77.86% |
2013 | 1.45 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 2.74 Million EUR | 5.44% |
2024 Q2 | 2.74 Million EUR | 0.0% |
2023 Q1 | 626.1 Thousand EUR | 125.36% |
2023 FY | 7.49 Million EUR | -0.92% |
2023 Q4 | 2.6 Million EUR | 0.0% |
2023 Q2 | 1.25 Million EUR | 100.0% |
2022 Q1 | 1.24 Million EUR | 286.03% |
2022 Q4 | 277.83 Thousand EUR | 100.0% |
2022 Q2 | 2.48 Million EUR | 100.0% |
2022 FY | 7.56 Million EUR | 190.46% |
2022 Q3 | 138.91 Thousand EUR | -94.4% |
2021 Q4 | -667.18 Thousand EUR | -94.01% |
2021 Q2 | 159.42 Thousand EUR | 77.13% |
2021 FY | 2.6 Million EUR | -42.86% |
2021 Q1 | 90 Thousand EUR | 61.7% |
2021 Q3 | -343.88 Thousand EUR | -315.71% |
2020 Q3 | 16.86 Thousand EUR | -98.86% |
2020 Q4 | 55.66 Thousand EUR | 229.97% |
2020 FY | 4.56 Million EUR | 396.75% |
2020 Q1 | 741.9 Thousand EUR | -69.21% |
2020 Q2 | 1.48 Million EUR | 100.0% |
2019 Q3 | 1.2 Million EUR | 5.58% |
2019 FY | 918.06 Thousand EUR | 20.9% |
2019 Q1 | 570.56 Thousand EUR | -25.21% |
2019 Q2 | 1.14 Million EUR | 100.0% |
2019 Q4 | 2.4 Million EUR | 100.0% |
2018 Q1 | 331.94 Thousand EUR | -61.27% |
2018 Q4 | 762.88 Thousand EUR | 0.0% |
2018 FY | 759.36 Thousand EUR | -58.54% |
2018 Q2 | 331.94 Thousand EUR | 0.0% |
2018 Q3 | 762.88 Thousand EUR | 129.82% |
2017 Q2 | 545.36 Thousand EUR | 0.0% |
2017 Q1 | 545.36 Thousand EUR | -72.92% |
2017 Q4 | 857.03 Thousand EUR | 0.0% |
2017 FY | 1.83 Million EUR | -72.2% |
2017 Q3 | 857.03 Thousand EUR | 57.15% |
2016 FY | 6.58 Million EUR | 203.24% |
2016 Q3 | 2.01 Million EUR | 57.35% |
2016 Q4 | 2.01 Million EUR | 0.0% |
2016 Q2 | 1.27 Million EUR | 0.0% |
2016 Q1 | 1.27 Million EUR | 55.68% |
2015 Q1 | 1.01 Million EUR | -16.93% |
2015 Q2 | -199.18 Thousand EUR | -119.66% |
2015 Q3 | 509.7 Thousand EUR | 355.89% |
2015 FY | 2.17 Million EUR | -16.17% |
2015 Q4 | 822.07 Thousand EUR | 61.29% |
2014 Q4 | 1.21 Million EUR | 102.8% |
2014 Q1 | 595.73 Thousand EUR | 3.34% |
2014 Q2 | 174.38 Thousand EUR | -70.73% |
2014 Q3 | 601.42 Thousand EUR | 244.89% |
2014 FY | 2.59 Million EUR | 77.86% |
2013 Q2 | 162.5 Thousand EUR | -74.45% |
2013 FY | 1.45 Million EUR | 0.0% |
2013 Q4 | 576.5 Thousand EUR | 603.82% |
2013 Q3 | 81.91 Thousand EUR | -49.6% |
2013 Q1 | 635.95 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Evrofarma SA | 3.65 Million EUR | -105.192% |
Flour Mills Kepenos S.A. | 3 Million EUR | -149.87% |
Kri-Kri Milk Industry S.A. | 39.21 Million EUR | 80.873% |